Bristol Myers Squibb Announces Positive Topline Results from Phase 3 TRANSFORM Trial Evaluating Breyanzi Versus Chemotherapy Followed by Stem Cell Transplant in Second-line Relapsed or Refractory Large B-cell Lymphoma Biotech Investing
BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET Biotech Investing
Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders Biotech Investing
BioHarvest Sciences Inc. Achieves Critical Milestones in the BioFarming of Cannabis Biotech Investing
Allergan Aesthetics and BOTOX® Cosmetic Put Real Stories at the Forefront in New Campaign Biotech Investing
Wellteq Signs Letter of Intent to Acquire Digital Sleep Solution Expanding Mental Health Capabilities Biotech Investing
CAPTIVATE Study Shows an IMBRUVICA® Plus VENCLEXTA®/VENCLYXTO® Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia Biotech Investing
